Umoja Biopharma logo

Umoja Biopharma

umoja-biopharma.com

Umoja Biopharma develops in vivo CAR T cell therapies that generate cancer-fighting T cells directly in a patient’s body. Its therapies are designed to treat cancers while making treatment more accessible by avoiding the multi-week cell manufacturing required for ex vivo CAR T therapies.

Facts

HQ
Seattle, WA 98109
Sectors
Biotechnology Research
Founded
2019
Type
Corporation Seattle business license
Employees
254
Registered name
Umoja Biopharma Inc Seattle business license
Members see funding amounts.
.

Is this your organization? Claim it

Founders

Executives

  • Nate Hardy Executive, Chief Financial Officer

Online